Home › NDC Lookup › RxCUI directory › RxCUI 1737245

2 ML clindamycin 150 MG/ML Injection [Cleocin] — RxCUI 1737245

RxNorm drug concept · Semantic branded drug
RxCUI 1737245 Semantic branded drug · SBD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1737245
Official name2 ML clindamycin 150 MG/ML Injection [Cleocin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCleocin Phosphate 300 MG per 2 ML Injection; Cleocin Phosphate 300 MG in 2 ML Injection; Cleocin (as clindamycin phosphate) 300 MG per 2 ML Injection
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)1,402 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clindamycin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats bacterial vaginosis, a vaginal infection caused by an imbalance of bacteria. It can be used in non-pregnant women and in pregnant women in the second and third trimester....
  • It's best not to. The cream contains mineral oil that can weaken latex condoms and diaphragms. Avoid them during treatment and for 5 days afterward, because they may not prevent pr...
  • Some women get a vaginal yeast infection or vaginal irritation. These were the most common in trials. Let your prescriber know if symptoms bother you.
  • Call if you get diarrhea, especially if it is bloody or doesn't go away. Antibiotics can allow a harmful bowel germ to overgrow, and this can happen even weeks after treatment. Als...
📖 Read our full Clindamycin Topical guide →

🕸️ Concept Web — How 2 ML clindamycin 150 MG/ML Injection [Cleocin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML clindamycin 150 MG/ML Injection [Cleocin] RxCUI 1737245

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clindamycin 2582
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cleocin 202862
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clindamycin Injection 1737230
    • Clindamycin Injectable Product 1152782
    • Clindamycin Injection [Cleocin] 1737232
    • Cleocin Injectable Product 1172329
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Clindamycin 150 MG/ML [Cleocin] SBDC · 706460
  • Clindamycin Injection [Cleocin] SBDF · 1737232
  • Cleocin Injectable Product SBDG · 1172329
  • Cleocin BN · 202862

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 1737245 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0728-09 5 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0009-0728-09) /... Cleocin Phosphate Pharmacia & Upjohn Company LLC 1972-10-02
00009-0775-26 25 VIAL in 1 CARTON (0009-0775-26) / 4 mL in 1 VIAL (0009-0... Cleocin Phosphate Pharmacia & Upjohn Company LLC 1972-10-02
00009-0870-26 25 VIAL in 1 CARTON (0009-0870-26) / 2 mL in 1 VIAL (0009-0... Cleocin Phosphate Pharmacia & Upjohn Company LLC 1972-10-02
00009-0902-18 25 VIAL in 1 CARTON (0009-0902-18) / 6 mL in 1 VIAL (0009-0... Cleocin Phosphate Pharmacia & Upjohn Company LLC 1972-10-02
00009-3051-02 25 VIAL in 1 CARTON (0009-3051-02) / 2 mL in 1 VIAL (0009-3... Cleocin Phosphate Pharmacia & Upjohn Company LLC 2019-11-18
00009-4073-04 25 VIAL in 1 CARTON (0009-4073-04) / 4 mL in 1 VIAL (0009-4... Cleocin Phosphate Pharmacia & Upjohn Company LLC 2019-11-18
00009-5095-06 25 VIAL in 1 CARTON (0009-5095-06) / 6 mL in 1 VIAL (0009-5... Cleocin Phosphate Pharmacia & Upjohn Company LLC 2019-11-18
00404-9837-02 1 VIAL in 1 BAG (0404-9837-02) / 2 mL in 1 VIAL CLEOCIN PHOSPHATE Henry Schein, Inc. 2022-01-09
71872-7324-01 1 VIAL in 1 BAG (71872-7324-1) / 2 mL in 1 VIAL Cleocin Phosphate Medical Purchasing Solutions, LLC 2024-02-02
Observed labelers: Pharmacia & Upjohn Company LLC (7) · Henry Schein, Inc. (1) · Medical Purchasing Solutions, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.2242
Range $1.2242–$1.2242 · middle 50% $1.2242–$1.2242 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0736 Inj, clindamycin phosp 300mg 8 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.